341(23):1715–1724. https://doi.org/10.
1056/nejm199912023412302
- Arad M, Maron BJ, Gorham JM, Johnson WH
Jr, Saul JP, Perez-Atayde AR, Spirito P, Wright
GB, Kanter RJ, Seidman CE, Seidman JG
(2005) Glycogen storage diseases presenting
as hypertrophic cardiomyopathy. N Engl J
Med 352(4):362–372. https://doi.org/10.
1056/NEJMoa033349. 352/4/362 [pii]
- Charron P, Genest M, Richard P, Komajda M,
Pochmalicki G (2007) A familial form of con-
duction defect related to a mutation in the
PRKAG2 gene. Europace 9(8):597–600.
https://doi.org/10.1093/europace/eum071.
eum071 [pii]
- Govindan M, Ward D, Behr E (2010) A rare
connection: fasciculoventricular pathway in
PRKAG2 disease. J Cardiovasc Electrophysiol
21(3):329–332. https://doi.org/10.1111/j.
1540-8167.2009.01578.x. JCE1578 [pii]
- Thevenon J, Laurent G, Ader F, Laforet P,
Klug D, Duva Pentiah A, Gouya L, Maurage
CA, Kacet S, Eicher JC, Albuisson J,
Desnos M, Bieth E, Duboc D, Martin L,
Reant P, Picard F, Bonithon-Kopp C,
Gautier E, Binquet C, Thauvin-Robinet C,
Faivre L, Bouvagnet P, Charron P, Richard P
(2017) High prevalence of arrhythmic and
myocardial complications in patients with car-
diac glycogenosis due to PRKAG2 mutations.
Europace 19(4):651–659. https://doi.org/
10.1093/europace/euw067
- Aggarwal V, Dobrolet N, Fishberger S,
Zablah J, Jayakar P, Ammous Z (2015)
PRKAG2 mutation: an easily missed cardiac
specific non-lysosomal glycogenosis. Ann
Pediatr Cardiol 8(2):153–156. https://doi.
org/10.4103/0974-2069.154149
- Sternick EB, Wellens HJJ (2006) Historical
notes and classification of the variants of ven-
tricular preexcitation. Variants of ventricular
preexcitation: recognition and treatment.
Blackwell Futura, Malden, MA
- Sternick EB, Gerken LM, Vrandecic MO, Well-
ens HJ (2003) Fasciculoventricular pathways:
clinical and electrophysiologic characteristics of
a variant of preexcitation. J Cardiovasc Electro-
physiol 14(10):1057–1063
- Sternick EB, Rodriguez LM, Gerken LM,
Wellens HJ (2005) Electrocardiogram in
patients with fasciculoventricular pathways: a
comparative study with anteroseptal and mid-
septal accessory pathways. Heart Rhythm 2
(1):1–6. https://doi.org/10.1016/j.hrthm.
2004.10.009
- Bayrak F, Komurcu-Bayrak E, Mutlu B,
Kahveci G, Basaran Y, Erginel-Unaltuna N
(2006) Ventricular pre-excitation and cardiac
hypertrophy mimicking hypertrophic cardio-
myopathy in a Turkish family with a novel
PRKAG2 mutation. Eur J Heart Fail 8
(7):712–715. https://doi.org/10.1016/j.
ejheart.2006.03.006. S1388-9842(06)
00072-9 [pii]
- Ponikowski P, Voors AA, Anker SD, Bueno H,
Cleland JG, Coats AJ, Falk V, Gonzalez-
Juanatey JR, Harjola VP, Jankowska EA,
Jessup M, Linde C, Nihoyannopoulos P, Par-
issis JT, Pieske B, Riley JP, Rosano GM, Rui-
lope LM, Ruschitzka F, Rutten FH, van der
Meer P (2016) 2016 ESC Guidelines for the
diagnosis and treatment of acute and chronic
heart failure: the Task Force for the diagnosis
and treatment of acute and chronic heart failure
of the European Society of Cardiology (ESC)
Developed with the special contribution of the
Heart Failure Association (HFA) of the ESC.
Eur Heart J 37(27):2129–2200.https://doi.
org/10.1093/eurheartj/ehw128
- Liu Y, Bai R, Wang L, Zhang C, Zhao R,
Wan D, Chen X, Caceres G, Barr D, Barajas-
Martinez H, Antzelevitch C, Hu D (2013)
Identification of a novel de novo mutation
associated with PRKAG2 cardiac syndrome
and early onset of heart failure. PLoS One 8
(5):e64603. https://doi.org/10.1371/jour
nal.pone.0064603
- Morita H, Rehm HL, Menesses A,
McDonough B, Roberts AE, Kucherlapati R,
Towbin JA, Seidman JG, Seidman CE (2008)
Shared genetic causes of cardiac hypertrophy in
children and adults. N Engl J Med 358
(18):1899–1908. https://doi.org/10.1056/
NEJMoa075463. NEJMoa075463 [pii]
- Poyhonen P, Hiippala A, Ollila L,
Kaasalainen T, Hanninen H, Helio T, Tallila J,
Vasilescu C, Kivisto S, Ojala T, Holmstrom M
(2015) Cardiovascular magnetic resonance
findings in patients with PRKAG2 gene muta-
tions. J Cardiovasc Magn Reson 17:89.
https://doi.org/10.1186/s12968-015-0192-
3
- Tong KL, Brown C, Ports TA, McGlothlin D,
De Marco T (2010) Alcohol septal ablation to
treat heart failure due to dynamic left ventricu-
lar outflow tract obstruction in a patient with
glycogen storage disease related to theprkag2
gene mutation. J Card Fail 16(8):S110.
https://doi.org/10.1016/j.cardfail.2010.06.
384
- Sternick EB, de Almeida Araujo S, Rocha C,
Gollob M (2014) Myocardial infarction in a
teenager. Eur Heart J 35(23):1558.https://
doi.org/10.1093/eurheartj/ehu015
- Ho CY, Charron P, Richard P, Girolami F, Van
Spaendonck-Zwarts KY, Pinto Y (2015)
PRKAG2 syndrome 617
